As previous mentioned, mutation or deletion of BAP1 may exhibit a correlation with the expression levels of PD-L1 in certain tumor types, such as malignant peritoneal/ pleural mesothelioma, thymic carcinoma and uveal melanoma [31, 34–36]. The gene discussed is BAP1; the disease is thymic carcinoma.